<?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?>
<?DTDIdentifier.IdentifierType schema?>
<?SourceDTD.DTDName xocs-article.xsd?>
<?SourceDTD.Version 1.0?>
<?ConverterInfo.XSLTName ftrr2jats.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Environ Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Environ Res</journal-id>
    <journal-title-group>
      <journal-title>Environmental Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0013-9351</issn>
    <issn pub-type="epub">1096-0953</issn>
    <publisher>
      <publisher-name>Elsevier Inc.</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8376833</article-id>
    <article-id pub-id-type="pii">S0013-9351(21)01204-4</article-id>
    <article-id pub-id-type="doi">10.1016/j.envres.2021.111909</article-id>
    <article-id pub-id-type="publisher-id">111909</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au1">
        <name>
          <surname>Bello</surname>
          <given-names>Xabier</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au2">
        <name>
          <surname>Pardo-Seco</surname>
          <given-names>Jacobo</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au3">
        <name>
          <surname>Gómez-Carballa</surname>
          <given-names>Alberto</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au4">
        <name>
          <surname>Weissensteiner</surname>
          <given-names>Hansi</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">c</xref>
      </contrib>
      <contrib contrib-type="author" id="au5">
        <name>
          <surname>Martinón-Torres</surname>
          <given-names>Federico</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff4" ref-type="aff">d</xref>
      </contrib>
      <contrib contrib-type="author" id="au6">
        <name>
          <surname>Salas</surname>
          <given-names>Antonio</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <aff id="aff1"><label>a</label>Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS) and Universidad de Santiago de Compostela (USC), Galicia, Spain</aff>
      <aff id="aff2"><label>b</label>Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Galicia, Spain</aff>
      <aff id="aff3"><label>c</label>Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, 6020, Innsbruck, Austria</aff>
      <aff id="aff4"><label>d</label>Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, Galicia, Spain</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Corresponding author. Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Galicia, Spain.</corresp>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>20</day>
      <month>8</month>
      <year>2021</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="ppub">
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>20</day>
      <month>8</month>
      <year>2021</year>
    </pub-date>
    <volume>204</volume>
    <fpage>111909</fpage>
    <lpage>111909</lpage>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>16</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>8</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Elsevier Inc. All rights reserved.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Elsevier Inc.</copyright-holder>
      <license>
        <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
      </license>
    </permissions>
    <abstract id="abs0010">
      <p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 genomes have been sequenced massively and worldwide and are now available in different public genome repositories. There is much interest in generating bioinformatic tools capable to analyze and interpret SARS-CoV-2 variation. We have designed CovidPhy (<ext-link ext-link-type="uri" xlink:href="http://covidphy.eu" id="intref0010">http://covidphy.eu</ext-link>), a web interface that can process SARS-CoV-2 genome sequences in plain fasta text format or provided through identity codes from the Global Initiative on Sharing Avian Influenza Data (GISAID) or GenBank. CovidPhy aggregates information available on the large GISAID database (&gt;1.49 M genomes). Sequences are first aligned against the reference sequence and the interface provides different sources of information, including automatic classification of genomes into a pre-computed phylogeny and phylogeographic information, haplogroup/lineage frequencies, and sequencing variation, indicating also if the genome contains known variants of concern (VOC). Additionally, CovidPhy allows searching for variants and haplotypes introduced by the user and includes a list of genomes that are good candidates for being responsible for large outbreaks worldwide, most likely mediated by important superspreading events, indicating their possible geographic epicenters and their relative impact as recorded in the GISAID database.</p>
    </abstract>
    <kwd-group id="kwrds0010">
      <title>Keywords</title>
      <kwd>SARS-CoV-2</kwd>
      <kwd>COVID-19</kwd>
      <kwd>RNA</kwd>
      <kwd>Superspreading events</kwd>
      <kwd>Variants of concern</kwd>
      <kwd>Phylogeny</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p id="p0030">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. There has been a massive interest in sequencing genomes from coronavirus circulating in COVID-19 patients worldwide since its first early sequencing in December 2019 (<xref rid="bib23" ref-type="bibr">Wu et al., 2020</xref>). Genomes are stored in public repositories such as GenBank (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sars-cov-2/" id="intref0015">https://www.ncbi.nlm.nih.gov/sars-cov-2/</ext-link>) or, more specifically, in The Global Initiative on Sharing Avian Influenza Data (GISAID; <ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org" id="intref0020">https://www.gisaid.org</ext-link>) (<xref rid="bib19" ref-type="bibr">Shu and McCauley, 2017</xref>) as well as the 2019 Novel Coronavirus Resource (2019nCoVR; <ext-link ext-link-type="uri" xlink:href="https://bigd.big.ac.cn/ncov/online/tools" id="intref0025">https://bigd.big.ac.cn/ncov/online/tools</ext-link>).</p>
    <p id="p0035">During the last few months, several software applications and web tools have been developed that aim at understanding SARS-CoV-2 variation as well as dissemination in a worldwide scale. One of the most popular tool is Nextstrain (<ext-link ext-link-type="uri" xlink:href="https://nextstrain.org" id="intref0030">https://nextstrain.org</ext-link> (<xref rid="bib8" ref-type="bibr">Hadfield et al., 2018</xref>)), which provides a maximum likelihood phylogeny built on a massive amount of SARS-CoV-2 genomes, and which allows to investigate the phylodynamics of the virus since the beginning of the pandemic. However, nomenclature of the Nextstrain phylogeny is limited to a few nodes among hundreds, it does not follow systematic criteria for naming clades, and it is not stable since it has undergone several changes over the last few months. Moreover, mutational pathways along branches from the root to a given node can only be reconstructed partially in most of the tree; therefore, although very informative from the phylodynamics point of view, the phylogeny does not allow to classify a genome into a phylogenetic node with the exception of a few nodes of interest (see, in contrast, human mtDNA phylogeny including 5,500 haplogroups (<xref rid="bib24" ref-type="bibr">van Oven, 2015</xref>) and related classification tools such as Haplogrep (<xref rid="bib22" ref-type="bibr">Weissensteiner et al., 2016</xref>). The tool Nextclade, which is part of the Nextstrain project, allows to classify SARS-CoV-2 fasta sequences into 18 major clades. Besides mutation calling and clade assignment, it performs some quality checks and phylogenetic placement in a global tree. The largest SARS-CoV-2 clade dataset is provided by the Pango Network comprising 1,801 virus lineages (out of which 514 lineages are withdrawn) with its own lineage naming rules (<xref rid="bib15" ref-type="bibr">Rambaut et al., 2020</xref>). Several tools for online and offline classification, lineage suggestion with an own lineage designation committee, tree modification and reporting are provided. Other analytical tools for the analysis of SARS-CoV-2 variation include CovSeq, a Python and JavaScript designed web interface (<xref rid="bib11" ref-type="bibr">Liu et al., 2020a</xref>) that aggregates data from different repositories to extract information on genetic variants that, ultimately, can be downloaded by users. The varSEAK database (<ext-link ext-link-type="uri" xlink:href="https://varseak.bio" id="intref0040">https://varseak.bio</ext-link>) offers a variety of analyses, providing information on variants, lineages, and a splice site prediction tool. Other software includes Viral Genome ORF Reader (VIGOR (<xref rid="bib21" ref-type="bibr">Wang et al., 2010</xref>)), which focuses on gene annotation, VAPiD (<xref rid="bib18" ref-type="bibr">Shean et al., 2019</xref>), a pipeline that facilitates genome submissions to NCBI GenBank, and the National Genomics Data Center (<xref rid="bib7" ref-type="bibr">Gong et al., 2020</xref>), an online tool that includes BLAST alignment, genome annotation, variant identification modules, among others utilities.</p>
    <p id="p0040">We have developed CovidPhy (<ext-link ext-link-type="uri" xlink:href="http://www.covidphy.eu" id="intref0045">www.covidphy.eu</ext-link>), a web tool that allows to process and analyze complete SARS-CoV-2 genomes. CovidPhy implements a pipeline that accepts newly generated sequencing fasta files, but also the identification codes of genomes stored in GISAID or GenBank repositories. It classifies genomes into main phylogenetic nodes and offers information on viral variants and clade frequencies worldwide.</p>
    <p id="p0045">By inspecting the large GISAID database, it makes it possible to identify specific SARS-CoV-2 sequences as strong candidates for being responsible for notable COVID-19 outbreaks. The first attempt was carried out by <xref rid="bib5" ref-type="bibr">Gómez-Carballa et al. (2020a)</xref>; in this early article, we explored the database available at that time (containing &gt;4.7 K SARS-CoV-2 genomes) for identical genomes that showed a high frequency in a short time frame (of only a few days) and occurring in specific geographic areas. This signature, coupled with the substitution rate of the SARS-CoV-2 (which generates a substitution approximately every two weeks) and the incubation period needed for the development of the COVID-19 symptoms (5–6 days, according to WHO on November 8, 2020) signaled the likely presence of sudden local outbreaks that could have been originated by superspreading events. Topological inspection of the phylogenies originated by these candidates added further support to a model of germ transmission compatible with superspreading and not with alternative ways of transmission (e.g. chains). This procedure was subsequently extended in <xref rid="bib6" ref-type="bibr">Gómez-Carballa et al. (2020b)</xref> to explore the important outbreaks occurring in Spain during the first wave of the pandemic, which was particularly devastating in this country. Further investigations corroborated the important role of superspreading in the COVID-19 pandemic (<xref rid="bib1" ref-type="bibr">Adam et al., 2020</xref>; <xref rid="bib2" ref-type="bibr">Althouse et al., 2020</xref>; <xref rid="bib12" ref-type="bibr">Liu et al., 2020b</xref>; <xref rid="bib20" ref-type="bibr">Walker et al., 2020</xref>). The article by <xref rid="bib10" ref-type="bibr">Lemieux et al. (2020)</xref> specifically treated two important outbreaks occurring in Boston in the early weeks of the pandemic; notably, one of these event had been recorded by our early analysis in <xref rid="bib5" ref-type="bibr">Gómez-Carballa et al. (2020a)</xref>; this feature was pointed out in <xref rid="bib17" ref-type="bibr">Salas et al. (2021)</xref>. Therefore, the identification of genomes that were responsible for important outbreaks in different countries and locations by simply inspecting the GISAID database constitutes another useful feature of CovidPhy.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Material and methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Data source and processing</title>
      <p id="p0050">CovidPhy uses data from GISAID to compute variant and clade (haplogroup) frequencies and infer SARS-CoV-2 candidates responsible for outbreaks. Genomes are aligned against the reference genome with GenBank accession number MN908947.3 (submitted on January 5, 2020) corresponding to the first SARS-CoV-2 genome released on GenBank (GISAID ID #402125). Most of the sequences used by CovidPhy were incrementally downloaded from GISAID since our initial publications and aligned to the reference sequence as previously indicated (<xref rid="bib5" ref-type="bibr">Gómez-Carballa et al. 2020a</xref>, <xref rid="bib6" ref-type="bibr">b</xref>; <xref rid="bib13" ref-type="bibr">Pardo-Seco et al., 2021</xref>; <xref rid="bib17" ref-type="bibr">Salas et al., 2021</xref>). A total of 1,493,746 genomes (downloaded on February 5, 2021 from GISAID) are now being processed in CovidPhy. We extracted the differences between any sequence and the reference, and the genomes were classified into the nodes of a pre-generated phylogeny.</p>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Phylogeny and nomenclature</title>
      <p id="p0055">We implemented the phylogeny (and nomenclature) built by <xref rid="bib5" ref-type="bibr">Gómez-Carballa et al., 2020a</xref>, <xref rid="bib6" ref-type="bibr">Gómez-Carballa et al., 2020b</xref> to classify SARS-CoV-2 genomes into clades; this is also available and navigable in the web interface. Although built on data produced during the first wave of the pandemic, to the best of our knowledge this phylogeny remains the most elaborate one available. The lack of a consensus nomenclature has generated great controversy among the scientific community (<ext-link ext-link-type="uri" xlink:href="https://www.newscientist.com/article/mg24933242-900-coronavirus-variant-names-are-too-confusing-there-is-a-better-way/" id="intref0050">https://www.newscientist.com/article/mg24933242-900-coronavirus-variant-names-are-too-confusing-there-is-a-better-way/</ext-link> (<xref rid="bib3" ref-type="bibr">Callaway, 2021</xref>)), as also echoed by the media (e.g. <ext-link ext-link-type="uri" xlink:href="https://www.nytimes.com/2021/03/02/health/virus-variant-names.html" id="intref0055">https://www.nytimes.com/2021/03/02/health/virus-variant-names.html</ext-link>), especially with the identification of new variants of concern (VOC) in late December 2020. We had already warned about this controversy in our early publication (<xref rid="bib5" ref-type="bibr">Gómez-Carballa et al., 2020a</xref>). Thereby, the differing naming for SARS-CoV-2 genetic lineages by GISAID, Nextstrain and Pango will remain by the scientific community, so that it seems most reasonable to keep the consistent nomenclature employed in the source mentioned. In addition, note also that the minimal nomenclature scheme employed by Nextstrain does not follows a systematic criteria for naming branches and the nomenclature is dynamic (see comments in (<xref rid="bib5" ref-type="bibr">Gómez-Carballa et al., 2020a</xref>)); this is also a common feature of the nomenclature used by <xref rid="bib15" ref-type="bibr">Rambaut et al. (2020</xref>, <xref rid="bib16" ref-type="bibr">2021</xref>). Instead, as of June 2021, The World Health Organization (WHO) proposed a new naming convention for VOCs and variants of interest (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/" id="intref0060">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</ext-link>) introducing letters of the Greek alphabet; CovidPhy provides classification of sequences into the four popular VOCs, namely, Alpha, Beta, Gamma and Delta. Together with this classification scheme, CovidPhy also identifies worrying mutations according to the CoVariants resource (<ext-link ext-link-type="uri" xlink:href="https://covariants.org/shared-mutations" id="intref0065">https://covariants.org/shared-mutations</ext-link>), many of these mutations are relevant to VOCs.</p>
    </sec>
    <sec id="sec2.3">
      <label>2.3</label>
      <title>Software stack</title>
      <p id="p0060">The whole stack was written in Nim programming language (<ext-link ext-link-type="uri" xlink:href="https://nim-lang.org" id="PC_link1z6YwukmaC">https://nim-lang.org</ext-link>). Nim is one of the best performing languages (<ext-link ext-link-type="uri" xlink:href="https://github.com/kostya/benchmarks" id="intref0070">https://github.com/kostya/benchmarks</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://github.com/def-/nim-benchmarksgame" id="intref0075">https://github.com/def-/nim-benchmarksgame</ext-link>), usually on par with C, without sacrificing readability and expressiveness.</p>
      <p id="p0065">The alignment of the input sequences is performed with a modified version of MAFFT (<xref rid="bib9" ref-type="bibr">Katoh and Standley, 2013</xref>), so it can be interfaced directly through a foreign function interface (FFI). The database of choice is SQLite (<ext-link ext-link-type="uri" xlink:href="https://www.sqlite.org/" id="intref0080">https://www.sqlite.org/</ext-link>), as we deemed that the strengths of that database (easy installation and management, capable of handling web traffic over 500 K hits/day) outweighed the weaknesses (not ready for high concurrency writes, no client/server structure). Nim can also compile to JavaScript, targeting the browser and allowing the developer to write the full stack of a web service in one single language.</p>
      <p id="p0070">The graphics for the webpage are created using Plotly (<ext-link ext-link-type="uri" xlink:href="https://plotly.com/javascript/" id="intref0085">https://plotly.com/javascript/</ext-link>), interfaced using Nim both in the frontend and in the backend. The web stack is a single binary, but the core (the aligner and the classifier) is decoupled, and therefore it could be reused to build also a graphical user interface (GUI) and command line interface (CLI) (<xref rid="fig1" ref-type="fig">Fig. 1</xref>
). We provide three main programs in the repository:<list list-type="simple" id="ulist0015"><list-item id="u0030"><label>•</label><p id="p0075">covidphy, the web server that can be reached at www.covidphy.eu;</p></list-item><list-item id="u0035"><label>•</label><p id="p0080">covidphy_cli, a command line interface that is used to classify sequences in our internal pipelines;</p></list-item><list-item id="u0040"><label>•</label><p id="p0085">covidphy_gui, a simple graphic interface for those unfamiliar with CLI, who may prefer to select the input with buttons</p></list-item></list>
<fig id="fig1"><label>Fig. 1</label><caption><p>Pipeline of CovidPhy. CovidPhy offers three interfaces: a web, a CLI and a GUI. All three can be fed with a fasta file (top left) that is aligned using <italic>libdistfast.so</italic> against the Reference (402,125) and scanned looking for differences that allow the classification in a precomputed phylogeny (top, red square marked “core”). The output varies for each program: the CLI and the GUI only output the haplogroup and the variants found (bottom black square), while the web offers additional information: haplogroup frequencies in regions (e.g. countries), candidates for important outbreaks as inferred from database searchers, and VOCs. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)</p></caption><alt-text id="alttext0010">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p>
    </sec>
    <sec id="sec2.4">
      <label>2.4</label>
      <title>Detection of outbreak candidates</title>
      <p id="p0090">Outbreak candidates were investigated in GISAID by searching identical haplotypes detected at least 30 times in a period of five consecutive days in a specific country or state (note however that these values might change in future updates of the tool depending on e.g. database size). Once an outbreak is detected, we determine its length by adding consecutive days after the identified event, so long as the displaced 5-day window meets the previous condition of at least 30 identical sequences; alternatively, we reduce the interval to the extreme if the number of counts equals to 0 while still satisfying the minimum criterion of at least 30 identical haplotypes in the shortened period. These analyses were carried out using R software (<xref rid="bib14" ref-type="bibr">R core Team, 2019</xref>).</p>
    </sec>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Results</title>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>Analysis carried out by CovidPhy</title>
      <p id="p0095">CovidPhy admits fasta files and can also run genomes provided through a GISAID or a GenBank identification code. The sequences are aligned against the SARS-CoV-2 reference sequence MN908947.3. New genomes are then investigated individually by exploring the variants present, their frequency information as extracted from the large GISAID database, and their phylogenetic allocation with regards to the reference phylogeny implemented in CovidPhy.</p>
      <p id="p0100">It takes about 0.1 s to align a single genome and carry out the clade classification; the rest of the analysis is even faster because the results displayed have been precomputed.</p>
      <p id="p0105">While sequence codes from NCBI can be retrieved automatically from the website, GISAID does not allow sharing genomes stored in their database; therefore, to investigate these sequences, the user must first register in the GISAID platform and download them the fasta files directly. When a GISAID code is entered, CovidPhy only provides information on its lineage/haplogroup assignation and frequency, but not on the variants involved.</p>
      <p id="p0110">For the genomes uploaded directly in the fasta text box or those indicated as a NCBI code, the user also obtains information on the variants present against the reference sequence (MN908947.3). This basic information includes the nucleotide position, the reference variant, and the alternative allele, the ORF assignation, the predicted severity of the variant for the virus (low: if synonymous; medium: if non-synonymous; high: if it leads to stop gain/loss, frameshift, or start loss), their functional description (missense, synonymous, etc.), and its frequency in the database. In addition, the user is informed if the sequence carries worrying mutations, indicating the nucleotide and the amino acid change (if any; e.g. A23063T (N501Y) that is characteristic of the B.1.1.7 and other VOC (<xref rid="bib4" ref-type="bibr">Davies et al., 2021</xref>)). Information on the length and coverage of the genomes is also provided (note that the 5′ and 3’ ends of the genomes stored in GISAID are usually missed).</p>
      <p id="p0115">Genomes are automatically classified into a clade according to the phylogeny provided by <xref rid="bib6" ref-type="bibr">Gómez-Carballa et al., 2020b</xref>, <xref rid="bib5" ref-type="bibr">Gómez-Carballa et al., 2020a</xref> and also indicates if the sequence is classified in any of the four most important VOC, but the algorithm can be applied to any classification tree. Once a sequence is classified into a clade, information is provided on the geographic location of this clade by way of displaying a continental map and including information on continental or country haplogroup frequencies. The phylogeny used by CovidPhy is provided in full in a tab. Briefly, there are two main clades that are phylogenetically located at the same level. Although there is not a clear consensus on the root of the tree (see a discussion in (<xref rid="bib5" ref-type="bibr">Gómez-Carballa et al., 2020a</xref>), the nomenclature is based on classical cladistics and, for practical purposes, it assumes the root in haplogroup A. Haplogroup names are organized and named hierarchically from this root: A &gt; A1 &gt; A1a &gt; A1a2, and the branch variants are indicated. By clicking on an haplogroup label, the user is moved to another tab indicating geographic frequencies of this lineag /haplogroup as well as the diagnostic mutational path that characterizes it.</p>
      <p id="p0120">Finally, another notable feature of CovidPhy is to search genomes carrying a particular variants or a set of variants in the GISAID database and selecting by country. For a specific query, the tool informs on the frequency of all the haplotypes in the database containing the variant(s) in the query through the time since the beginning of the pandemic.</p>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>Outbreaks recorded in SARS-CoV-2 databases</title>
      <p id="p0125">By inspecting the large database of GISAID, it is possible to identify specific SARS-CoV-2 sequences as good candidates for being responsible for large sudden COVID-19 outbreaks triggered by superspreading events. These events are listed in CovidPhy by geographic region and by country. Information is provided on the number of sequences represented in the database for the exponential growth period, and the relative frequency of the responsible genome against the other genomes circulating in the same region during the same timeframe.</p>
      <p id="p0130">Lineage assignation of the candidate genome is provided, and the continental frequency of this haplogroup can also be graphically displayed on a map.</p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Discussion</title>
    <p id="p0135">The COVID-19 pandemic has impacted every region of the world. There is much interest in investigating and tracking evolutionary characteristics of SARS-CoV-2 variants and lineages. Apart from the interest of CovidPhy for research, there is also demand from e.g. microbiological units in hospitals lacking the bioinformatic tools for the treatment of the genome sequences that they generate on a daily basis. There are similar tools available that can process SARS-CoV-2 genome sequences and carry out different kinds of analyses. Compared to previous developments, CovidPhy offers additional features. For instance, it automatically classifies a given genome into a clade by providing a SARS-CoV-2 phylogeny, and to provide phylogeographic information for this genome. Additionally, it allows variant(s) searches in the large GISAID database providing with information on frequencies for haplotypes containing the queried variation. It also provides information on lineages that have played a critical role in the dispersal of the SARS-CoV-2 pathogen, by initiating rapid and sudden outbreaks across the world.</p>
    <p id="p0140">CovidPhy has been specifically designed for treating information on the SARS-CoV-2 sequences, but it can be easily scaled to other microorganisms of interest for which large datasets are available. (e.g. for influenza in GISAID).</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Declaration of competing interest</title>
    <p id="p0145">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
  </sec>
</body>
<back>
  <ref-list id="cebib0010">
    <title>References</title>
    <ref id="bib1">
      <element-citation publication-type="journal" id="sref1">
        <person-group person-group-type="author">
          <name>
            <surname>Adam</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>J.Y.</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>E.H.Y.</given-names>
          </name>
          <name>
            <surname>Tsang</surname>
            <given-names>T.K.</given-names>
          </name>
          <name>
            <surname>Cauchemez</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Leung</surname>
            <given-names>G.M.</given-names>
          </name>
          <name>
            <surname>Cowling</surname>
            <given-names>B.J.</given-names>
          </name>
        </person-group>
        <article-title>Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong</article-title>
        <source>Nat. Med.</source>
        <volume>26</volume>
        <year>2020</year>
        <fpage>1714</fpage>
        <lpage>1719</lpage>
        <pub-id pub-id-type="pmid">32943787</pub-id>
      </element-citation>
    </ref>
    <ref id="bib2">
      <element-citation publication-type="journal" id="sref2">
        <person-group person-group-type="author">
          <name>
            <surname>Althouse</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Wenger</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Scarpino</surname>
            <given-names>S.V.</given-names>
          </name>
          <name>
            <surname>Allard</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hebert-Dufresne</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Superspreading events in the transmission dynamics of SARS-CoV-2: opportunities for interventions and control</article-title>
        <source>PLoS Biol.</source>
        <volume>18</volume>
        <year>2020</year>
        <object-id pub-id-type="publisher-id">e3000897</object-id>
      </element-citation>
    </ref>
    <ref id="bib3">
      <element-citation publication-type="journal" id="sref3">
        <person-group person-group-type="author">
          <name>
            <surname>Callaway</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>'A bloody mess': confusion reigns over naming of new COVID variants</article-title>
        <source>Nature</source>
        <volume>589</volume>
        <year>2021</year>
        <object-id pub-id-type="publisher-id">339</object-id>
      </element-citation>
    </ref>
    <ref id="bib4">
      <element-citation publication-type="journal" id="sref4">
        <person-group person-group-type="author">
          <name>
            <surname>Davies</surname>
            <given-names>N.G.</given-names>
          </name>
          <name>
            <surname>Abbott</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Barnard</surname>
            <given-names>R.C.</given-names>
          </name>
          <name>
            <surname>Jarvis</surname>
            <given-names>C.I.</given-names>
          </name>
          <name>
            <surname>Kucharski</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Munday</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Pearson</surname>
            <given-names>C.A.B.</given-names>
          </name>
          <name>
            <surname>Russell</surname>
            <given-names>T.W.</given-names>
          </name>
          <name>
            <surname>Tully</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Washburne</surname>
            <given-names>A.D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England</article-title>
        <source>Science</source>
        <volume>372</volume>
        <year>2021</year>
      </element-citation>
    </ref>
    <ref id="bib5">
      <element-citation publication-type="journal" id="sref5">
        <person-group person-group-type="author">
          <name>
            <surname>Gómez-Carballa</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bello</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Pardo-Seco</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Martinón-Torres</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Salas</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders</article-title>
        <source>Genome Res.</source>
        <volume>30</volume>
        <year>2020</year>
        <fpage>1434</fpage>
        <lpage>1448</lpage>
        <pub-id pub-id-type="pmid">32878977</pub-id>
      </element-citation>
    </ref>
    <ref id="bib6">
      <element-citation publication-type="journal" id="sref6">
        <person-group person-group-type="author">
          <name>
            <surname>Gómez-Carballa</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bello</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Pardo-Seco</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pérez Del Molino</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Martinón-Torres</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Salas</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders</article-title>
        <source>Zool. Res.</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.24272/j.issn.2095-8137.2020.217:1-16</pub-id>
      </element-citation>
    </ref>
    <ref id="bib7">
      <element-citation publication-type="journal" id="sref7">
        <person-group person-group-type="author">
          <name>
            <surname>Gong</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>J.W.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C.P.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>L.N.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>B.X.</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y.B.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>S.H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An online coronavirus analysis platform from the National Genomics Data Center</article-title>
        <source>Zool. Res.</source>
        <volume>41</volume>
        <year>2020</year>
        <fpage>705</fpage>
        <lpage>708</lpage>
        <pub-id pub-id-type="pmid">33045776</pub-id>
      </element-citation>
    </ref>
    <ref id="bib8">
      <element-citation publication-type="journal" id="sref8">
        <person-group person-group-type="author">
          <name>
            <surname>Hadfield</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Megill</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Huddleston</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Potter</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Callender</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Sagulenko</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Bedford</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Neher</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Nextstrain: real-time tracking of pathogen evolution</article-title>
        <source>Bioinformatics</source>
        <volume>34</volume>
        <year>2018</year>
        <fpage>4121</fpage>
        <lpage>4123</lpage>
        <pub-id pub-id-type="pmid">29790939</pub-id>
      </element-citation>
    </ref>
    <ref id="bib9">
      <element-citation publication-type="journal" id="sref9">
        <person-group person-group-type="author">
          <name>
            <surname>Katoh</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Standley</surname>
            <given-names>D.M.</given-names>
          </name>
        </person-group>
        <article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title>
        <source>Mol. Biol. Evol.</source>
        <volume>30</volume>
        <year>2013</year>
        <fpage>772</fpage>
        <lpage>780</lpage>
        <pub-id pub-id-type="pmid">23329690</pub-id>
      </element-citation>
    </ref>
    <ref id="bib10">
      <element-citation publication-type="journal" id="sref10">
        <person-group person-group-type="author">
          <name>
            <surname>Lemieux</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Siddle</surname>
            <given-names>K.J.</given-names>
          </name>
          <name>
            <surname>Shaw</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Loreth</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Schaffner</surname>
            <given-names>S.F.</given-names>
          </name>
          <name>
            <surname>Gladden-Young</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Adams</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Fink</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Tomkins-Tinch</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Krasilnikova</surname>
            <given-names>L.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events</article-title>
        <source>Science</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1126/science.abe3261</pub-id>
      </element-citation>
    </ref>
    <ref id="bib11">
      <element-citation publication-type="journal" id="sref11">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Bian</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>CoV-seq, a new tool for SARS-CoV-2 genome analysis and visualization: development and usability study</article-title>
        <source>J. Med. Internet Res.</source>
        <volume>22</volume>
        <year>2020</year>
        <object-id pub-id-type="publisher-id">e22299</object-id>
      </element-citation>
    </ref>
    <ref id="bib12">
      <element-citation publication-type="journal" id="sref12">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Eggo</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Kucharski</surname>
            <given-names>A.J.</given-names>
          </name>
        </person-group>
        <article-title>Secondary attack rate and superspreading events for SARS-CoV-2</article-title>
        <source>Lancet</source>
        <volume>395</volume>
        <year>2020</year>
        <object-id pub-id-type="publisher-id">e47</object-id>
      </element-citation>
    </ref>
    <ref id="bib13">
      <element-citation publication-type="journal" id="sref13">
        <person-group person-group-type="author">
          <name>
            <surname>Pardo-Seco</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Gomez-Carballa</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bello</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Martinon-Torres</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Salas</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics</article-title>
        <source>Zool. Res.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.24272/j.issn.2095-8137.2020.364:1-7</pub-id>
      </element-citation>
    </ref>
    <ref id="bib14">
      <element-citation publication-type="book" id="sref14">
        <person-group person-group-type="author">
          <collab>R core Team</collab>
        </person-group>
        <part-title>R: A Language and Environment for Statistical Computing</part-title>
        <year>2019</year>
        <publisher-name>R Foundation for Statistical Computing</publisher-name>
        <publisher-loc>Vienna, Austria</publisher-loc>
      </element-citation>
    </ref>
    <ref id="bib15">
      <element-citation publication-type="journal" id="sref15">
        <person-group person-group-type="author">
          <name>
            <surname>Rambaut</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>E.C.</given-names>
          </name>
          <name>
            <surname>O'Toole</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>McCrone</surname>
            <given-names>J.T.</given-names>
          </name>
          <name>
            <surname>Ruis</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>du Plessis</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Pybus</surname>
            <given-names>O.G.</given-names>
          </name>
        </person-group>
        <article-title>A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology</article-title>
        <source>Nat. Microbiol.</source>
        <volume>5</volume>
        <year>2020</year>
        <fpage>1403</fpage>
        <lpage>1407</lpage>
        <pub-id pub-id-type="pmid">32669681</pub-id>
      </element-citation>
    </ref>
    <ref id="bib16">
      <element-citation publication-type="journal" id="sref16">
        <person-group person-group-type="author">
          <name>
            <surname>Rambaut</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>E.C.</given-names>
          </name>
          <name>
            <surname>O'Toole</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>McCrone</surname>
            <given-names>J.T.</given-names>
          </name>
          <name>
            <surname>Ruis</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>du Plessis</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Pybus</surname>
            <given-names>O.G.</given-names>
          </name>
        </person-group>
        <article-title>Addendum: a dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology</article-title>
        <source>Nat. Microbiol.</source>
        <volume>6</volume>
        <year>2021</year>
        <object-id pub-id-type="publisher-id">415</object-id>
      </element-citation>
    </ref>
    <ref id="bib17">
      <element-citation publication-type="journal" id="sref17">
        <person-group person-group-type="author">
          <name>
            <surname>Salas</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bello</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Pardo-Seco</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Martinón-Torres</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Gómez-Carballa</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Superspreading: the engine of the SARS-CoV-2 pandemic</article-title>
        <source>Science</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1126/science.abe3261</pub-id>
      </element-citation>
    </ref>
    <ref id="bib18">
      <element-citation publication-type="journal" id="sref18">
        <person-group person-group-type="author">
          <name>
            <surname>Shean</surname>
            <given-names>R.C.</given-names>
          </name>
          <name>
            <surname>Makhsous</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Stoddard</surname>
            <given-names>G.D.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>A.L.</given-names>
          </name>
        </person-group>
        <article-title>VAPiD: a lightweight cross-platform viral annotation pipeline and identification tool to facilitate virus genome submissions to NCBI GenBank</article-title>
        <source>BMC Bioinf.</source>
        <volume>20</volume>
        <year>2019</year>
        <fpage>48</fpage>
      </element-citation>
    </ref>
    <ref id="bib19">
      <element-citation publication-type="journal" id="sref19">
        <person-group person-group-type="author">
          <name>
            <surname>Shu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>McCauley</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>GISAID: global initiative on sharing all influenza data - from vision to reality</article-title>
        <source>Euro Surveill.</source>
        <volume>22</volume>
        <year>2017</year>
      </element-citation>
    </ref>
    <ref id="bib24">
      <element-citation publication-type="journal" id="optly7M54nFNh">
        <person-group person-group-type="author">
          <name>
            <surname>van Oven</surname>
            <given-names>Mannis</given-names>
          </name>
        </person-group>
        <article-title>PhyloTree Build 17: Growing the human mitochondrial DNA tre</article-title>
        <source>Forensic Sci. Int.: Genet. Suppl. Series</source>
        <volume>5</volume>
        <year>2015</year>
        <fpage>e392</fpage>
        <lpage>e394</lpage>
        <pub-id pub-id-type="doi">10.1016/j.fsigss.2015.09.155</pub-id>
      </element-citation>
    </ref>
    <ref id="bib20">
      <element-citation publication-type="journal" id="sref20">
        <person-group person-group-type="author">
          <name>
            <surname>Walker</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Houwaart</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Wienemann</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Vasconcelos</surname>
            <given-names>M.K.</given-names>
          </name>
          <name>
            <surname>Strelow</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Senff</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Hulse</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Adams</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Andree</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hauka</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020</article-title>
        <source>Euro Surveill.</source>
        <volume>25</volume>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="bib21">
      <element-citation publication-type="journal" id="sref21">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sundaram</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Spiro</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>VIGOR, an annotation program for small viral genomes</article-title>
        <source>BMC Bioinf.</source>
        <volume>11</volume>
        <year>2010</year>
        <object-id pub-id-type="publisher-id">451</object-id>
      </element-citation>
    </ref>
    <ref id="bib22">
      <element-citation publication-type="journal" id="sref22">
        <person-group person-group-type="author">
          <name>
            <surname>Weissensteiner</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Pacher</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Kloss-Brandstätter</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Forer</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Specht</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Bandelt</surname>
            <given-names>H.-J.</given-names>
          </name>
          <name>
            <surname>Kronenberg</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Salas</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Schonherr</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>44</volume>
        <year>2016</year>
        <fpage>W58</fpage>
        <lpage>W63</lpage>
        <pub-id pub-id-type="pmid">27084951</pub-id>
      </element-citation>
    </ref>
    <ref id="bib23">
      <element-citation publication-type="journal" id="sref23">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.M.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Z.G.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>Z.W.</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>J.H.</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>Y.Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A new coronavirus associated with human respiratory disease in China</article-title>
        <source>Nature</source>
        <volume>579</volume>
        <year>2020</year>
        <fpage>265</fpage>
        <lpage>269</lpage>
        <pub-id pub-id-type="pmid">32015508</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <ack id="ack0010">
    <title>Acknowledgements</title>
    <p id="p0150">We gratefully acknowledge GISAID and contributing laboratories for giving us access to the SAR-CoV-2 genome database. This study received support from projects: GePEM (<funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos</institution></institution-wrap></funding-source> III(ISCIII)/PI16/01478/Cofinanciado FEDER), DIAVIR (<funding-source id="gs4">Instituto de Salud Carlos</funding-source> III(ISCIII)/DTS19/00049/Cofinanciado FEDER; Proyecto de Desarrollo Tecnológico en Salud), Resvi-Omics (<funding-source id="gs5">Instituto de Salud Carlos</funding-source> III (ISCIII)/PI19/01039/Cofinanciado FEDER), BI-BACVIR (PRIS-3; Agencia de Conocimiento en Salud (ACIS)—Servicio Gallego de Salud (SERGAS)—Xunta de Galicia; Spain), Programa Traslaciona Covid-19 (ACIS—Servicio Gallego de Salud (SERGAS)—Xunta de Galicia; Spain) and <funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100010769</institution-id><institution>Axencia Galega de Innovación</institution></institution-wrap></funding-source> (GAIN; IN607B 2020/08—Xunta de Galicia; Spain) awarded to A.S.; and projects ReSVinext (<funding-source id="gs6">Instituto de Salud Carlos</funding-source> III (ISCIII)/PI16/01569/Cofinanciado FEDER), Enterogen (<funding-source id="gs7">Instituto de Salud Carlos</funding-source> III(ISCIII)/PI19/01090/Cofinanciado FEDER), and <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100010769</institution-id><institution>Axencia Galega de Innovación</institution></institution-wrap></funding-source> (GAIN; IN845D 2020/23—Xunta de Galicia; Spain) awarded to F.M.-T.</p>
  </ack>
</back>
